December 23, 2024

Hormone Combo Linked to Autoimmune Risk

Combination hormone therapy was associated with higher risk for a range of autoimmune conditions in a recent study.

Conexiant

December 20, 2024

New Arthritis Findings Span Two Decades

New research reveals increased risk factors for psoriatic arthritis in patients with juvenile idiopathic arthritis over an 18-year study period in the Nordic region.

Conexiant

December 16, 2024

Arthritis Drugs Linked to Fracture Risk

Current gabapentinoid use in patients with inflammatory arthritis was associated with a 36% higher odds of fractures compared to remote use, with risks persisting across most dose levels and showing marked impact shortly after drug initiation.

Conexiant

December 11, 2024

Colectomy Raises AKI, Kidney Failure Risk in IBD

A recent study has revealed that patients with inflammatory bowel disease face elevated risks of acute kidney injury and chronic kidney failure after undergoing colectomy, with certain factors increasing these risks. Read more about the study in Clinical Gastroenterology and Hepatology.

Conexiant

December 11, 2024

Osteosarcopenia: Stiffness-Balance Link

A study on postmenopausal women reveals significant reductions in muscle-tendon stiffness and balance control in osteosarcopenia, emphasizing the importance of targeted rehabilitation exercises. (Source: Aging Clinical and Experimental Research)

Conexiant

November 27, 2024

MS Proteome Changes Linked to Aging

A recent study investigates the impact of aging on the cerebrospinal fluid proteome in multiple sclerosis patients, revealing changes in inflammatory markers and potential therapeutic targets. Source: Published Study

Conexiant

November 27, 2024

Key Risk Factors for SARD-ILD Progression

A recent review identified significant risk factors for the progression of systemic autoimmune rheumatic disease-associated interstitial lung disease, emphasizing the importance of early identification and intervention for high-risk patients. The findings provide evidence-based insights for clinicians to guide risk assessment and optimize care.

Conexiant

November 26, 2024

PsA Clusters Identified for Tailored Treatment: Longitudinal Study

A recent study reveals significant treatment response improvements in severe psoriatic arthritis and extensive psoriasis, emphasizing the need for personalized treatment strategies and sensitive outcome measures. (Source: Psoriatic Arthritis Research Consortium)

Conexiant

November 26, 2024

Do Cancer Drugs Trigger Skin Issues?

A recent analysis reveals that nearly 50% of significant dermatologic adverse events linked to anticancer therapies are associated with targeted therapies, with rash, dry skin, and alopecia being the most commonly reported adverse events.

Conexiant